Log in
Enquire now
‌

US Patent 10398706 Heteroaryldiazepine derivatives as RSV inhibitors

Patent 10398706 was granted and assigned to Enanta Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Current Assignee
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103987060
Patent Inventor Names
Brian C. Shook0
Joseph Panarese0
Thomas P. Blaisdell0
Yat Sun Or0
In Jong Kim0
Jianming Yu0
Date of Patent
September 3, 2019
0
Patent Application Number
158632160
Date Filed
January 5, 2018
0
Patent Citations Received
‌
US Patent 12006326 Antiviral heterocyclic compounds
0
‌
US Patent 10975094 Heterocyclic compounds as RSV inhibitors
0
‌
US Patent 11254664 Benzodiazepine derivatives as RSV inhibitors
‌
US Patent 11390631 Benzodiazepine derivatives as RSV inhibitors
‌
US Patent 11420976 Heterocyclic compounds as anti-viral agents
‌
US Patent 11912695 Benzodiazepine derivatives as RSV inhibitors
0
‌
US Patent 11945830 Antiviral heterocyclic compounds
0
‌
US Patent 11945824 Heterocyclic compounds as anti-viral agents
0
...
Patent Primary Examiner
‌
Brenda L Coleman
0
Patent abstract

The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10398706 Heteroaryldiazepine derivatives as RSV inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.